1) Chan JF, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission : a study of a family cluster. Lancet. 2020 ; 395 (10223) : 514-23.
2) Li Q, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 ; 382 (13) : 1199-207.
3) Guan WJ, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 ; 382 (18) : 1708-20.
5) Qin J, et al. Estimation of incubation period distribution of COVID-19 using disease onset forward time : a novel cross-sectional and forward follow-up study. medRxiv. 2020.
6) 国立国際医療研究センター. COVID-19 レジストリ研究に関する中間報告について. 2020. http://www.ncgm.go.jp/covid19/0806_handouts.pdf (2020年9月10日閲覧)
7) Zayet S, et al. Clinical features of COVID-19 and influenza : a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020.
8) Struyf T, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020 ; 7 (7) : CD013665.
9) Tong JY, et al. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients : A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2020 ; 163 (1) : 3-11.
10) Cheung KS, et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort : Systematic Review and Meta-analysis. Gastroenterology. 2020 ; 159 (1) : 81-95.
11) Oran DP, et al. Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Ann Intern Med. 2020 ; 173 (5) : 362-7.
12) Cohen PA, et al. The Early Natural History of SARS-CoV-2 : InfectionClinical Observations From an Urban, Ambulatory COVID-19 Clinic. Mayo Clin Proc. 2020 ; 95 (6) : 1124-6.
13) Wang D, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 ; 323 (11) : 1061-9.
14) Wu Z, et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China : Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 ; 323 (13) : 1239-42.
15) 厚生労働省. "臨床像". 新型コロナウイルス感染症 (COVID-19) 診療の手引き. 第3版. 2020. 9. https://www.mhlw.go.jp/content/000668291.pdf (2020年9月10日閲覧)
16) Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) : People with Certain Medical Conditions. http://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (2020年9月11日閲覧)
17) Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) : Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19. 2020. http://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html (2020年9月11日閲覧)
18) UpToDate(R). Coronavirus disease 2019 (COVID-19) : Clinical features. 2020. https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-clinical-features (2020年10月1日閲覧)
19) Stokes EK, et al. Coronavirus Disease 2019 Case Surveillance-United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 ; 69 (24) : 759-65.
20) Verity R, et al. Estimates of the severity of coronavirus disease 2019 : a model-based analysis. Lancet Infect Dis. 2020 ; 20 (6) : 669-77.
21) Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 ; 584 (7821) : 430-6.
22) Infectious Diseases Society of America. COVID-19 Prioritization of Diagnostic Testing. 2020. http://www.idsociety.org/globalassets/idsa/public-health/covid-19-prioritization-of-dx-testing.pdf (2020年9月11日閲覧)
23) Centers for Disease Control and Prevention. Overview of Testing for SARS-CoV-2 (COVID-19). 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html (2020年9月11閲覧)
24) Infectious Diseases Society of America. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19. 2020. https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/diagnostics/idsacovid-19-guideline_dx_version-1.0.1.pdf (2020年9月11日閲覧)
25) 東京都新型コロナウイルス感染症対策サイト. 都内の最新感染動向. 2020. https://stopcovid19.metro.tokyo.lg.jp/cards/positive-rate/ (2020年9月11日閲覧)
26) He X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020 ; 26 (5) : 672-5.
27) Bullard J, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020.
28) Liu WD, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020 ; 81 (2) : 318-56.
29) Centers for Disease Control and Prevention. Clinical Questions about COVID-19 : Questions and Answers. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html (2020年9月11日閲覧)